keyword
MENU ▼
Read by QxMD icon Read
search

Antiarrhymic

keyword
https://www.readbyqxmd.com/read/21955243/dofetilide-reduces-the-frequency-of-ventricular-arrhythmias-and-implantable-cardioverter-defibrillator-therapies
#1
Giselle A Baquero, Javier E Banchs, Sondra Depalma, Sallie K Young, Erica D Penny-Peterson, Soraya M Samii, Deborah L Wolbrette, Gerald V Naccarelli, Mario D Gonzalez
BACKGROUND: Patients with an implanted cardioverter defibrillator (ICD) and ventricular arrhythmias leading to ICD therapies have poor clinical outcomes and quality of life. Antiarrhythmic agents and catheter ablation are needed to control these arrhythmias. Dofetilide has only been approved for the treatment of atrial fibrillation. The role of dofetilide in the control of ventricular arrhythmias in patients with an ICD has not been established. OBJECTIVE: Evaluate the safety and efficacy of dofetilide in a consecutive group of patients with an ICD and recurrent ventricular tachycardia (VT) and/ or ventricular fibrillation (VF) after other antiarrhythmic drugs have failed to suppress these arrhythmias...
March 2012: Journal of Cardiovascular Electrophysiology
https://www.readbyqxmd.com/read/15609115/integrating-cost-effectiveness-evidence-into-clinical-practice-guidelines-in-australia-for-acute-myocardial-infarction
#2
K M Antioch, G Jennings, M Botti, R Chapman, V Wulfsohn
A teaching hospital is working with the Victorian State Government and universities, integrating cost-effectiveness evidence into clinical practice guidelines (CPGs), protocols and pathways for respiratory and cardiology interventions. Acute myocardial infarction (AMI) findings are reported. Results will stimulate cost-effective practice and inform medical associations, federal and state governments and international organisations developing CPGs. Published CPGs by the American College of Cardiology/American Heart Foundation for AMI in 1999 are reviewed by a large interdisciplinary hospital-based committee given cost-effectiveness evidence...
2002: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/15460915/a-patient-with-sustained-ventricular-tachycardia-identification-of-a-responder-to-amiodarone-using-signal-averaged-electrocardiogram
#3
Ayaka Kobayashi, Masahiro Nomura, Yuko Sawa, Takashi Kawaguchi, Kunihiko Koshiba, Koji Yamaguchi, Tomohito Kawano, Tetsuzo Wakatsuki, Tomotsugu Tabata, Akiyoshi Nisikado, Susumu Ito, Yutaka Nakaya
A 75-year-old man suffered sustained ventricular tachycardia with syncopal attack. Ventricular tachycardias appeared repeatedly, and an electrical defibrillator was used after an anti-arrhythmic drug, such as lidocaine or mexiletine, proved ineffective. The tachycardias had multiple origins, and the signal-averaged electrocardiogram (SAECG) showed ventricular late potential before the administration of amiodarone. After administration, the filtered QRS and duration of the late potential increased, but the recurrence of tachycardias was suppressed...
August 2004: Journal of Medical Investigation: JMI
https://www.readbyqxmd.com/read/11941400/-inhibition-of-transmembrane-k-currents-in-mammalian-ventricular-myocytes-by-antiarrhythmic-agent-rp62719
#4
Y R Li, B F Yang, C Q Xu, J Zhou, Y B Yang, J Y Zhang, M Z Sun
The effect of RP62719 on the inward rectifier K(+) current (I(K1)),transient outward K(+) current (I(to)) and delayed outward K(+) current (I(K)) in isolated cardiac myocytes was determined using the whole cell patch clamp technique in guinea pig and dog. RP62719 decreased I(K1) with an inhibitory concentration 50 (IC(50) ) of 5.0+/-1.0 micromol/L at -100 mV in guinea pig ventricular cells. In dog ventricular myocytes, RP62719 inhibited Ito by 84+/-4.4% with an IC(50) of 1.2+/-0.51 micromol/L at +40 mV. In guinea pig ventricular cells, RP62719 decreased I(K): I(Kstep) by 50...
October 2000: Sheng Li Xue Bao: [Acta Physiologica Sinica]
https://www.readbyqxmd.com/read/74154/the-efficacy-of-intravenous-mexiletine-on-ventricular-ectopic-activity
#5
A Waleffe, H E Kulbertus
Twelve patients with severe ventricular dysrhythmias were treated by one single dose of 250 mg of mexiletine injected intravenously over a 15 min. period. All patients showed some antiarrhythmic response. In 9 cases, the ventricular premature beats were totally or almost totally abolished up to 20 to 100 min. after the end of the infection. In most patients (5/7), there existed a correlation between the plasma concentration of the drug and the antiarrhymic action. However, the drug levels were not different in the good responders as compared to the poor responders or in those who manifested a prolonged antiarrhythmic activity as compared to the others...
1977: Acta Cardiologica
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"